YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Analysis of Current Status and Drug Expenditure of Drug Shortage Prevention Program

퇴장방지의약품관리제도의 운영 현황과 약품비 분석

  • Chae, Su-Mi (Headquarter for Health Policy Research, Korea Institute for Health and Social Affairs) ;
  • Lee, Eui-Kyung (Graduate School of Clinical Pharmacy, Sookmyung Women’s University)
  • 채수미 (한국보건사회연구원 보건의료연구본부) ;
  • 이의경 (숙명여자대학교 임상약학대학원)
  • Published : 2008.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study investigated the current status and drug expenditure of the drug shortage prevention program in Korea. National health insurance claims data from 2001 to 2005 were analyzed for the drugs with inadequate supply, which were designated as shortage prevention drugs (SPDs). Drug use of SPDs have increased every year, but the average increase rate of drug expenditure for SPDs, 13.5% was lower than that for all the reimbursed drugs, 18.6%. Drugs with price increase based on production cost were more actively used than drugs with prescription incentives for doctors.

Keywords

References

  1. 보건복지부, 퇴장방지의약품 선정 및 관리내용 통보, 행정지침 급여 65720-10006호 (2000)
  2. WHO : The world medicines situation, p. 115 (2004)
  3. WHO : WHO medicines strategy: framework for action in essential drugs and medicines policy 2000-2003 (2000)
  4. The selection and use of essential medicines, Report of the WHO Expert Committee (including the 13th Model List of Essential Medicines), WHO Technical Report Series, No.920 (2003)
  5. 후생성, 약가인상요청 예정품목의 연락에 대하여, 일본 약사관련통지 제546호 (2001)
  6. Jensen, V., Kimzey, L. M. and Goldberger, M. J. : FDA's role in responding to drug shortages. Am. J. Health Syst. Pharm. 28, 1423 (2002)
  7. Nordenberg, T. : When a drug is in short supply. FDA Consume. 31, 30 (1997)
  8. www.fda.gov/cder/durg/shortages
  9. www.cdc.gov/nip/news/shortages/
  10. Fox, E. R. and Tyler, L. S. : Measuring the impact of drug shortages. Am. J. Health Syst. Pharm. 61, 2009 (2004)
  11. Fox, E. R. and Tyler, L. S. : Managing drug shortages: seven year's experience at one health system. Am. J. Health Syst. Pharm. 60, 245 (2003)
  12. www.ashp.org/shortage
  13. 보건복지부, 퇴장방지의약품 사용 활성화 방안, 행정지침 급여 65720-586호 (2003)